Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
British Journal of Haematology
|
February 1, 1993
The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products
C R Prentice, K K Hampton, P J Grant, et al.
Neurochemical Research
|
May 1, 1990
Changes in cerebral inositol-1-phosphate concentrations in LiCl-treated rats: regional and strain differences
K M Savolainen, M R Hirvonen, J Tarhanen, et al.
Neuroscience
|
January 1, 1987
Cholinergic systems influence local cerebral glucose use in specific anatomical areas: diisopropyl phosphorofluoridate versus soman
L Churchill, T L Pazdernik, R S Cross, et al.
Brain Research
|
May 22, 1992
Patterns of glucose use after bicuculline-induced convulsions in relationship to gamma-aminobutyric acid and mu-opioid receptors in the ventral pallidum--functional markers for the ventral pallidum
L Churchill, R S Cross, T L Pazdernik, et al.
Neurotoxicology
|
January 1, 1985
Soman-induced brain lesions demonstrated by muscarinic receptor autoradiography
L Churchill, T L Pazdernik, J L Jackson, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
April 1, 1984
Soman induced changes in brain regional glucose use
F E Samson, T L Pazdernik, R S Cross, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 30, 1991
Serum amyloid P component in chronic renal failure and dialysis
S R Nelson, G A Tennent, D Sethi, et al.
The Journal of School Health
|
October 1, 1985
Selecting and recruiting health programs for the School Health Education Evaluation
S L Owen, M A Kirkpatrick, S W Lavery, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 7, 1994
Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure
M B Pepys, T W Rademacher, S Amatayakul-Chantler, et al.
Lancet (London, England)
|
August 10, 1991
Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component
S R Nelson, P N Hawkins, S Richardson, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
British Journal of Haematology
|
February 1, 1993
The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products
C R Prentice, K K Hampton, P J Grant, et al.
Neurochemical Research
|
May 1, 1990
Changes in cerebral inositol-1-phosphate concentrations in LiCl-treated rats: regional and strain differences
K M Savolainen, M R Hirvonen, J Tarhanen, et al.
Neuroscience
|
January 1, 1987
Cholinergic systems influence local cerebral glucose use in specific anatomical areas: diisopropyl phosphorofluoridate versus soman
L Churchill, T L Pazdernik, R S Cross, et al.
Brain Research
|
May 22, 1992
Patterns of glucose use after bicuculline-induced convulsions in relationship to gamma-aminobutyric acid and mu-opioid receptors in the ventral pallidum--functional markers for the ventral pallidum
L Churchill, R S Cross, T L Pazdernik, et al.
Neurotoxicology
|
January 1, 1985
Soman-induced brain lesions demonstrated by muscarinic receptor autoradiography
L Churchill, T L Pazdernik, J L Jackson, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
April 1, 1984
Soman induced changes in brain regional glucose use
F E Samson, T L Pazdernik, R S Cross, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 30, 1991
Serum amyloid P component in chronic renal failure and dialysis
S R Nelson, G A Tennent, D Sethi, et al.
The Journal of School Health
|
October 1, 1985
Selecting and recruiting health programs for the School Health Education Evaluation
S L Owen, M A Kirkpatrick, S W Lavery, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 7, 1994
Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure
M B Pepys, T W Rademacher, S Amatayakul-Chantler, et al.
Lancet (London, England)
|
August 10, 1991
Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component
S R Nelson, P N Hawkins, S Richardson, et al.
Page
of 9